There’s a character in the musical “Wicked” that I strongly relate to. She has the cutest slippers in the film, and her first day at Shiz University barely hints at the whirlwind of tragedies that await her. Throughout the story, she spends much of her time trying to prove herself.

It’s that time of year when people are thinking about resolutions, things they can do to improve themselves in 2026. Whether it’s losing weight, gaining muscle, learning a new skill, or going on an adventure, many of us like to set goals, make plans, and hope that, by…

Every December, I write an end-of-the-year column. I try to make it inspiring, or at the very least optimistic, but sometimes I can’t even accomplish that. Last year’s wrap-up was essentially a long-winded way of me saying, “See you never, 2024, and good riddance.” For the most part, though,…

Throughout 2025, the team at SMA News Today has brought our audience the latest advances in spinal muscular atrophy (SMA), from emerging treatments and clinical trial updates to real-world research. As the year comes to a close, we’ve taken a look back at the top 10 stories that…

A medicine called leuprorelin acetate, approved in the U.S. to treat prostate cancer, can slow the progression of physical disability in people with spinal and bulbar muscular atrophy (SBMA), according to an analysis of a real-world study from Japan. Given certain limitations in the study’s design, the researchers stressed that…